RecruitingNCT05863910

Real World Evidence on the Use of Medical Cannabis in Pediatrics

Real World Evidence on the Use of Medical Cannabis in Pediatrics: A Prospective Observational Study


Sponsor

University of Manitoba

Enrollment

500 participants

Start Date

Nov 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

CAN-RWE is an observational study that is following 500 children who have authorizations for medical cannabis for two years from across Canada.


Eligibility

Min Age: 3 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This study collects real-world information about how medical cannabis affects children and teenagers who are legally prescribed it in Canada for conditions like pain, sleep problems, seizures, mood, behavior, or cancer-related symptoms. **Your child may be eligible if...** - They are between 3 and 17 years old - They have a valid medical prescription for cannabis from a licensed healthcare provider - The cannabis is being used for pain, sleep, mood, behavior, seizures, or cancer-related symptoms - They are able to respond to online questionnaires in English **Your child may NOT be eligible if...** - They are using cannabis without a proper medical authorization - They are using cannabis recreationally, not medically Talk to your child's doctor to see if this study is right for your family.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMedical Cannabis

Any cannabis product that is available to participants through the Medical Cannabis Access Program is eligible to be included in this study.


Locations(1)

U Manitoba

Winnipeg, Manitoba, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05863910


Related Trials